Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Insulin pricing and other major diabetes-related concerns in the USA: A study of 46,407 Tweets between 2017 and 2019

Adrian Ahne, Francisco Orchard, Xavier Tannier, Camille Perchoux, Beverley Balkau, Sherry Pagoto, Jessica L Harding, Thomas Czernichow, View ORCID ProfileGuy Fagherazzi
doi: https://doi.org/10.1101/2020.01.04.20016527
Adrian Ahne
1Inserm U1018, Center for Research in Epidemiology and Population Health (CESP), Paris Saclay University, Gustave Roussy Institute, 114 rue Edouard Vaillant, 94800 Villejuif, France
2Epiconcept, 47 rue de Charenton, 75012 Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francisco Orchard
2Epiconcept, 47 rue de Charenton, 75012 Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xavier Tannier
3Inserm UMRS 1142, LIMICS, 15 rue de l’école de médecine, 75006 Paris, France
4Sorbonne Université, 4 Place Jussieu, 75005 Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Camille Perchoux
5Luxembourg Institute of Socio-Economic Research (LISER), Esch/Alzette, 11 Porte des Sciences, 4366 Esch-sur-Alzette, Luxembourg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beverley Balkau
1Inserm U1018, Center for Research in Epidemiology and Population Health (CESP), Paris Saclay University, Gustave Roussy Institute, 114 rue Edouard Vaillant, 94800 Villejuif, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sherry Pagoto
6UConn Center for mHealth & Social Media, University of Connecticut, 2006 Hillside Road, Unit 1248, Storrs, CT 06269-1248, Connecticut, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica L Harding
7Division of Transplantation, Department of Surgery, Emory University School of Medicine, Emory University Hospital, 101 Woodruff Circle NE, Suite 5127 Woodruff Memorial Research Bldg Atlanta, Georgia 30322 United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Czernichow
2Epiconcept, 47 rue de Charenton, 75012 Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guy Fagherazzi
1Inserm U1018, Center for Research in Epidemiology and Population Health (CESP), Paris Saclay University, Gustave Roussy Institute, 114 rue Edouard Vaillant, 94800 Villejuif, France
8Luxembourg Institute of Health; Department of Population Health, 1A-B, rue Thomas Edison, L-1445 Strassen, Luxembourg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Guy Fagherazzi
  • For correspondence: Guy.Fagherazzi@lih.lu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Introduction Little research has been done to systematically evaluate concerns of people living with diabetes through social media, which has been a powerful tool for social change and to better understand perceptions around health-related issues. This study aims to identify key diabetes-related concerns in the USA and primary emotions associated with those concerns using information shared on Twitter.

Research Design and Methods A total of 11.7 million diabetes-related tweets in English were collected between April 2017 and July 2019. Machine learning methods were used to filter tweets with personal content, to geolocate (to the US) and to identify clusters of tweets with emotional elements. A sentiment analysis was then applied to each cluster.

Results We identified 46,407 tweets with emotional elements in the USA from which 30 clusters were identified; five clusters (18% of tweets) were related to insulin pricing with both positive emotions (joy, love) referring to advocacy for affordable insulin and sadness emotions related to the frustration of insulin prices, five clusters (12% of tweets) to solidarity and support with a majority of joy and love emotions expressed. The most negative topics (10% of tweets) were related to diabetes distress (24% sadness, 27% anger, 21% fear elements), to diabetic and insulin shock (45% anger, 46% fear) and comorbidities (40% sadness).

Conclusions Using social media data, we have been able to describe key diabetes-related concerns and their associated emotions. More specifically, we were able to highlight the real-world concerns of insulin pricing and its negative impact on mood. Using such data can be a useful addition to current measures that inform public decision making around topics of concern and burden among people with diabetes.

What is already known about this subject?

  • It is very challenging to collect representative data at a population level to understand what are the key concerns of people with diabetes in real life.

  • Social media platforms, such as Twitter, may serve as a relevant source of information to supplement traditional population health studies.

  • There are worldwide inequalities in access to insulin.

What are the new findings?

  • With 18% of the tweets related to insulin pricing, this is a major concern in the diabetes community in the USA.

  • People regularly express fear, anger and sadness about potential diabetes-related complications and comorbidities.

  • However, there is a lot of support and solidarity among the diabetes online community, with numerous posts related to positive emotions

How might these results change the focus of research or clinical practice?

  • Our work presents a reproducible approach to easily capture information about key diabetes-related concerns, that is usually not available in typical clinical or epidemiological studies. This information can supplement data from clinical or epidemiological studies to inform public health strategies to deal with diabetes-related prevention, management and treatment

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work has been supported by the MSDAvenir Foundation, the French Speaking Diabetes Society and the Luxembourg Institute of Health. These study sponsors had no role in the design nor the interpretation of the results of the present study. Adrian Ahne, Francisco Orchard and Thomas Czernichow are supported by Epiconcept Company. Epiconcept was involved in the data collection and writing of the report. No study sponsor influenced the decision to submit the paper for publication.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All code is publicly available in this github repository: https://github.com/WDDS/Tweet-Diabetes-Classification Data is available upon reasonable request

https://github.com/WDDS/Tweet-Diabetes-Classification

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted April 07, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Insulin pricing and other major diabetes-related concerns in the USA: A study of 46,407 Tweets between 2017 and 2019
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Insulin pricing and other major diabetes-related concerns in the USA: A study of 46,407 Tweets between 2017 and 2019
Adrian Ahne, Francisco Orchard, Xavier Tannier, Camille Perchoux, Beverley Balkau, Sherry Pagoto, Jessica L Harding, Thomas Czernichow, Guy Fagherazzi
medRxiv 2020.01.04.20016527; doi: https://doi.org/10.1101/2020.01.04.20016527
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Insulin pricing and other major diabetes-related concerns in the USA: A study of 46,407 Tweets between 2017 and 2019
Adrian Ahne, Francisco Orchard, Xavier Tannier, Camille Perchoux, Beverley Balkau, Sherry Pagoto, Jessica L Harding, Thomas Czernichow, Guy Fagherazzi
medRxiv 2020.01.04.20016527; doi: https://doi.org/10.1101/2020.01.04.20016527

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (227)
  • Allergy and Immunology (501)
  • Anesthesia (110)
  • Cardiovascular Medicine (1233)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (529)
  • Epidemiology (10012)
  • Forensic Medicine (5)
  • Gastroenterology (498)
  • Genetic and Genomic Medicine (2448)
  • Geriatric Medicine (236)
  • Health Economics (479)
  • Health Informatics (1636)
  • Health Policy (751)
  • Health Systems and Quality Improvement (635)
  • Hematology (248)
  • HIV/AIDS (532)
  • Infectious Diseases (except HIV/AIDS) (11860)
  • Intensive Care and Critical Care Medicine (625)
  • Medical Education (252)
  • Medical Ethics (74)
  • Nephrology (268)
  • Neurology (2277)
  • Nursing (139)
  • Nutrition (350)
  • Obstetrics and Gynecology (452)
  • Occupational and Environmental Health (534)
  • Oncology (1245)
  • Ophthalmology (375)
  • Orthopedics (133)
  • Otolaryngology (226)
  • Pain Medicine (155)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (729)
  • Pharmacology and Therapeutics (311)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2280)
  • Public and Global Health (4828)
  • Radiology and Imaging (834)
  • Rehabilitation Medicine and Physical Therapy (490)
  • Respiratory Medicine (650)
  • Rheumatology (283)
  • Sexual and Reproductive Health (237)
  • Sports Medicine (226)
  • Surgery (266)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)